Clinical Trial Update: Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term nightly and intermittent dosing of zolpidem for insomnia. The study is completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Psychophysiological Insomnia

Drugs mentioned

• Ambien (zolpidem)

Snippet

Sponsor: University of Rochester | Conditions: Insomnia, Primary Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2013-05-16